TABLE 9.
Top 10 cited references in severe asthma drug-related studies.
| Rank | Author/year | Cited reference | Source | Frequency |
|---|---|---|---|---|
| 1 | Bleecker et al. (2016) | Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomized, multicenter, placebo-controlled phase 3 trial | Lancet | 633 |
| 2 | Salpeter et al. (2006) | Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths | Annals of Internal Medicine | 371 |
| 3 | Hekking et al. (2015) | Prevalence of severe refractory asthma | Journal of Allergy and Clinical Immunology | 341 |
| 4 | Alexander et al. (1992) | Trial of cyclosporin in corticosteroid-dependent chronic severe asthma | Lancet | 329 |
| 5 | Holgate and Polosa (2006) | Mechanisms, diagnosis, and management of severe asthma in adults | Lancet | 278 |
| 6 | Hanania et al. (2015) | Lebrikizumab in moderate-to-severe asthma: pooled data from two randomized placebo-controlled studies | Thorax | 269 |
| 7 | Brightling et al. (2015) | Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomized, double-blind, placebo-controlled phase 2 b trial | Lancet Respiratory Medicine | 253 |
| 8 | Engelkes et al. (2015) | Medication adherence and the risk of severe asthma exacerbations: a systematic review | European Respiratory Journal | 220 |
| 9 | Wenzel (2005) | Severe asthma in adults | American Journal of Respiratory and Critical Care Medicine | 217 |
| 10 | McFadden (2003) | Acute severe asthma | American Journal of Respiratory and Critical Care Medicine | 183 |